Skip to main content

The Alaska Native/American Indian Experience of Hepatitis C Treatment With Sofosbuvir-based Direct-acting Antivirals

About the Course

The study aims to evaluate the effectiveness of sofosbuvir-based hepatitis C treatment regimens among Alaska Native and American Indian (AN/AI) people living in Alaska, and to determine if there are any differences in treatment experience and outcomes compared to other racial and ethnic groups. The study is conducted by the Liver Disease and Hepatitis program (LDHP) at the Alaska Native Tribal Health Consortium (ANTHC), which has a registry and an established cohort of AN/AI individuals with HCV infection. The study is motivated by the high rates of HCV in Alaska and the need to address disparities in HCV treatment among AN/AI populations. The effectiveness of hepatitis C treatment and the potential impact of eliminating the disease are also discussed, highlighting the advancements in treatment with the introduction of direct-acting antivirals (DAAs).

This course is based on the reading-based online article, The Alaska Native/American Indian Experience of Hepatitis C Treatment With Sofosbuvir-based Direct-acting Antivirals created by Lisa Townshend-Bulson, ANP et al. in 2021.

Publication Date

1st Edition Dec 2021

Course Material Authors

Course Material Authors authored the material only, and were not involved in creating this CE course. They are identified here for your own evaluation of the relevancy of the material this course is based on.

Lisa Townshend-Bulson, ANP

Lisa Townshend-Bulson is a nurse practitioner in Anchorage, Alaska and is associated with the Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program. She has been in practice for more than twenty years and has multiple works published in peer reviewed journals.

Elena Roik, MD, PhD, MPH

Dr. Roik serves as the Director of the Alaska Native Tumor Registry and the Principal Investigator for the Alaska Surveillance, Epidemiology and End Results (SEER) Program of the National Cancer Institute. She has had multiple works published in peer reviewed journals.

Course Creator

Allison Brown, LCSW 149014591

Allison Brown holds a BS degree in Criminal Justice with a Psychology focus and a Master’s degree in Social Work from Loyola University Chicago. She is a Licensed Clinical Social Worker who currently works at a Long-Term Insurance company bringing clinical experience to claim processes. Additionally, she developed and continues to lead the Continuing Education Program for Social Workers and Nurses and often leads complex process improvement projects Prior to this, her primary focus was in mental health and worked in both the outpatient and inpatient settings providing support to adults with mental illness.

Recommended For

Counselors, marriage and family therapists, psychologists and social workers. This course is appropriate for all levels of knowledge.

Course Objectives:

After taking this course, you should be able to:

  1. Understand the epidemiology and impact of hepatitis C virus (HCV) infection among Alaska Native and American Indian (AN/AI) populations, including the high rates of infection and associated liver-related complications such as hepatocellular carcinoma (HCC) and end-stage liver disease (ESLD).
  2. Examine the effectiveness of sofosbuvir-based hepatitis C treatment regimens among AN/AI individuals in Alaska, including the efficacy, treatment duration, and side effects of direct-acting antivirals (DAAs) compared to interferon-based therapies.
  3. Identify any disparities in treatment experience and outcomes among AN/AI people with HCV infection in Alaska as compared to other racial and ethnic groups, including the potential impact on HCV elimination efforts and improving health outcomes for this population.

Availability

This course is available starting Jul 29th, 2024 and expires Jul 28th, 2034

Disclosure to Learners

Disclosure of Relevant Financial Relationships

Exam Questions

All exam questions for the course are visible on this page for members of Addiction Counselor CE.

Membership is free, and you can register today! You'll only pay when you're ready to purchase a course, or if you take advantage of the Unlimited Package.

If you're already a member, please sign in to see the exam questions for this and all other courses.

Discuss this course

You can share your thoughts about this course after you pass the exam.

Sign In or Register to get started.

FAQs

  • Is this course approved for my continuing education requirements?

  • Do you have accommodations for my disability (ADA)?

  • How do I enroll in this course?

  • What do I have to do to complete the course?

  • How do I access the materials?

  • How do I get my certificate?

  • Can I contact you for more help?

Course Number 103529
1 CE credit hour
Sign in for credit hours relevant to your credentials.

  • Reading-Based Online
Exam Fee $5.97
There's no exam fee with an Unlimited CE membership! Read More

No Cost Materials

2 members have taken this course

Try a free CE course.

Get started by trying a free course of your choice. No payment info required!

Sign Up Free

View all free trial courses

Happy therapist using Addiction Counselor CE